Chiocca EA - Search Results

1

Cytochrome p450-based gene therapies for cancer.

Chiocca EA, Waxman DJ. Chiocca EA, et al. Methods Mol Med. 2004;90:203-22. doi: 10.1385/1-59259-429-8:203. Methods Mol Med. 2004. PMID: 14657565 Review. No abstract available.

2

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene.

Wei MX, Tamiya T, Chase M, Boviatsis EJ, Chang TK, Kowall NW, Hochberg FH, Waxman DJ, Breakefield XO, Chiocca EA. Wei MX, et al. Among authors: chiocca ea. Hum Gene Ther. 1994 Aug;5(8):969-78. doi: 10.1089/hum.1994.5.8-969. Hum Gene Ther. 1994. PMID: 7948146

3

New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.

Rainov NG, Dobberstein KU, Sena-Esteves M, Herrlinger U, Kramm CM, Philpot RM, Hilton J, Chiocca EA, Breakefield XO. Rainov NG, et al. Among authors: chiocca ea. Hum Gene Ther. 1998 Jun 10;9(9):1261-73. doi: 10.1089/hum.1998.9.9-1261. Hum Gene Ther. 1998. PMID: 9650611

4

Diffusible cytotoxic metabolites contribute to the in vitro bystander effect associated with the cyclophosphamide/cytochrome P450 2B1 cancer gene therapy paradigm.

Wei MX, Tamiya T, Rhee RJ, Breakefield XO, Chiocca EA. Wei MX, et al. Among authors: chiocca ea. Clin Cancer Res. 1995 Oct;1(10):1171-7. Clin Cancer Res. 1995. PMID: 9815909

5

Neurogenetic surgery: current limitations and the promise of gene- and virus-based therapies.

Carter BS, Zervas NT, Chiocca EA. Carter BS, et al. Among authors: chiocca ea. Clin Neurosurg. 1999;45:226-46. Clin Neurosurg. 1999. PMID: 10461522 Review. No abstract available.

6

Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies.

Aghi M, Chou TC, Suling K, Breakefield XO, Chiocca EA. Aghi M, et al. Among authors: chiocca ea. Cancer Res. 1999 Aug 15;59(16):3861-5. Cancer Res. 1999. PMID: 10463570

7

Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA.

Saeki Y, Breakefield XO, Chiocca EA. Saeki Y, et al. Among authors: chiocca ea. Methods Mol Med. 2003;76:51-60. doi: 10.1385/1-59259-304-6:51. Methods Mol Med. 2003. PMID: 12526158 No abstract available.

8

Progress and prospects: gene therapy clinical trials (part 2).

Aiuti A, Bachoud-Lévi AC, Blesch A, Brenner MK, Cattaneo F, Chiocca EA, Gao G, High KA, Leen AM, Lemoine NR, McNeish IA, Meneguzzi G, Peschanski M, Roncarolo MG, Strayer DS, Tuszynski MH, Waxman DJ, Wilson JM. Aiuti A, et al. Among authors: chiocca ea. Gene Ther. 2007 Nov;14(22):1555-63. doi: 10.1038/sj.gt.3303033. Gene Ther. 2007. PMID: 17984995 Review.

9

Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy.

Ono Y, Ikeda K, Wei MX, Harsh GR 4th, Tamiya T, Chiocca EA. Ono Y, et al. Among authors: chiocca ea. Hum Gene Ther. 1997 Nov 20;8(17):2043-55. doi: 10.1089/hum.1997.8.17-2043. Hum Gene Ther. 1997. PMID: 9414253

10

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies.

Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA. Aghi M, et al. Among authors: chiocca ea. J Natl Cancer Inst. 1998 Mar 4;90(5):370-80. doi: 10.1093/jnci/90.5.370. J Natl Cancer Inst. 1998. PMID: 9498487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

449 results

Search Page